2.4 Neonatal & Special Population Assessment: Finnegan, Eat-Sleep-Console & Life Stages

Neonatal & Special Population Assessment: Finnegan, Eat-Sleep-Console & Life Stages

Neonatal Opioid Withdrawal Syndrome (NOWS) Assessment

Neonatal Opioid Withdrawal Syndrome (NOWS)—historically termed Neonatal Abstinence Syndrome (NAS)—occurs in newborns exposed to opioids in utero following abrupt discontinuation of maternal transplacental passage at birth. NOWS manifests as multi-system dysfunction primarily affecting the central nervous system (CNS), gastrointestinal (GI) tract, and respiratory system.

Nurses caring for neonates at risk for NOWS must perform serial, standardized assessments to monitor withdrawal trajectory and determine when non-pharmacological interventions or morphine/methadone pharmacotherapy are required.

---

The Modified Finnegan Neonatal Abstinence Scoring System (FNASS)

The Modified Finnegan (FNASS) has long served as the traditional high-density scoring tool for NOWS. It evaluates 21 physical signs scored every 3 to 4 hours post-feed.

FNASS Symptom Domain Categorization

Clinical Decision Thresholds for FNASS

• Score < 8: Mild withdrawal symptoms. Continue non-pharmacological care (rooming-in, swaddling, quiet environment).
• Score ≥ 8 on 2 consecutive scoring periods OR Score ≥ 12 on a single scoring period: Threshold for initiating pharmacological therapy (typically oral morphine or methadone) alongside non-pharmacological measures.

---

The Eat, Sleep, Console (ESC) Care Model

In recent years, pediatric and addiction nursing has undergone a major paradigm shift from symptom-counting tools like FNASS to the Eat, Sleep, Console (ESC) care model. Developed by Grossman et al., ESC centers on functional baby-centered capabilities rather than subtle neurodevelopmental signs.

Core Functional Assessment Criteria under ESC

1. Can the infant EAT adequately? (Feeds appropriate for gestational age: e.g., ≥15–30 mL per feed or effective breastfeeding for ≥10–15 minutes per side without distress).
2. Can the infant SLEEP soundly? (Sleeps undisturbed for at least 1 hour following a feed).
3. Can the infant be CONSOLED within 10 minutes? (If crying, can the infant be comforted to a calm state within 10 minutes by a caregiver using non-pharmacological measures?).

Eat, Sleep, Console (ESC) Clinical Decision Flow:
Assessed Post-Feed:
[EAT: Feed OK?] + [SLEEP: Sleep >=1h?] + [CONSOLE: Consoled <10m?]
       |                                      |
    ALL YES                                ANY NO
       v                                      v
Maintain Non-Pharm Care              Maximize Non-Pharm Care
(Rooming-In, Skin-to-Skin,           (Team Huddle, 24/7 Rooming-In)
Low Stimulation)                     If persistent functional deficit:
                                     Consider Pharmacotherapy

Impact of ESC on Nursing Care & Clinical Outcomes

ESC prioritizes parental rooming-in, skin-to-skin contact, quiet dark rooms, and frequent low-volume feedings as the primary treatment. Pharmacotherapy is reserved exclusively for infants with persistent functional deficits despite optimized non-pharmacological care. Large clinical trials demonstrate that ESC dramatically reduces pharmacological treatment rates (from ~50% to <15%) and cuts NICU length of stay from 20+ days to under 6 days.

---

Perinatal & Pregnant Population Assessment

Screening pregnant individuals for substance use requires a trauma-informed, non-stigmatizing framework. Fear of legal repercussions, child protective services (CPS) involvement, and societal stigma represent severe barriers to disclosure.

Key Nursing Standards for Perinatal Assessment

• Universal Screening: Universal verbal screening using validated tools (e.g., 4Ps Plus, SURP-P, NIDA Quick Screen) should occur at the initial prenatal visit.
• Informed Consent for Toxicology: Urine drug screening (UDS) MUST NOT be conducted without explicit informed consent, complying with medical ethics and patient autonomy.
• Opioid Maintenance Priority: Pregnant patients with Opioid Use Disorder must be transitioned immediately to agonist maintenance therapy (Methadone or Buprenorphine). Acute detoxification is contraindicated during pregnancy due to high rates of relapse and severe fetal stress/stillbirth caused by withdrawal-induced uterine hypertonicity.

---

Geriatric Substance Use Disorder Assessment

Substance use among older adults (aged 65+) is frequently underdiagnosed due to ageist assumptions and symptom overlap with chronic medical illness or neurocognitive decline.

Age-Related Pharmacokinetic & Assessment Nuances

• Altered Pharmacokinetics: Decreased hepatic cytochrome P450 clearance, reduced glomerular filtration rate (GFR), decreased total body water, and increased body fat ratio lead to higher peak serum concentrations and prolonged drug half-lives.
• Diagnostic Masking: Alcohol or sedative misuse in older adults often manifests as recurrent falls, cognitive slowing, memory loss, sleep disturbances, or unexplainable bruises—frequently misattributed to dementia or normal aging.
• Screening Instrument: The MAST-G (Michigan Alcoholism Screening Test – Geriatric Version) or AUDIT-C (with a reduced positive cut-off score of ≥3) are the validated screening standards for older adults.

---

Adolescent & Transition-Age Youth Assessment

Adolescent substance use evaluation requires recognizing unique developmental dynamics. The adolescent brain features an accelerated limbic reward system coupled with an immature prefrontal cortex, driving heightened risk-taking behavior.

Essential Nursing Considerations for Adolescent Evaluation

• Confidentiality Boundaries: Nurses must explain state-specific minor consent laws and confidentiality limits (e.g., mandatory reporting for active suicidal intent, physical abuse, or severe self-harm).
• Screening Standard: CRAFFT screening tool should be universally applied.
• Ecological Context: Assess family dynamics, peer influence, school performance, and history of adverse childhood experiences (ACEs).